“Japanese drug firm Daiichi Sankyo announced the acquisition of a majority stake of more than 50 per cent in Ranbaxy for over Rs 15,000 crore” according to Economic Times.
It represents an interesting development;
- First, Indian firms could get such high valuation internationally, proving he arrival of the truly India-born MNC’s.
- Second, promoters are ready to accept reality than get bogged down by emotion.
- Third, globalization has made the full circle in India; Tata acquiring Corus steel, India-born Lakshmi Mittal emerging as the largest global steel company thru Arcelor- Mittal; and, Ranbaxy being acquired by a Japanese company.
Interesting times indeed.
Tags: Daiichi Sankyo, Indian companies being acquired by global corporations, Japanese, Ranbaxy
